Global Stock News

Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Article feature image

Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (Rani Therapeutics or Rani), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics…

Click here to view the original article.

Share this article

Scroll to Top